These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12939285)

  • 41. A quantitative analysis of frog optic nerve regeneration: is retrograde ganglion cell death or collateral axonal loss related to selective reinnervation?
    Stelzner DJ; Strauss JA
    J Comp Neurol; 1986 Mar; 245(1):83-106. PubMed ID: 3485663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.
    Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH
    Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA
    Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
    Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
    Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.
    Swier VJ; White KA; Johnson TB; Wang X; Han J; Pearce DA; Singh R; Drack AV; Pfeifer W; Rogers CS; Brudvig JJ; Weimer JM
    Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37305926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.
    Kleine Holthaus SM; Aristorena M; Maswood R; Semenyuk O; Hoke J; Hare A; Smith AJ; Mole SE; Ali RR
    Hum Gene Ther; 2020 Jul; 31(13-14):709-718. PubMed ID: 32578444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Burkovetskaya M; Karpuk N; Kielian T
    Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of age on nerve fibers in the rhesus monkey optic nerve.
    Sandell JH; Peters A
    J Comp Neurol; 2001 Jan; 429(4):541-53. PubMed ID: 11135234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiply myelinated axons in the optic nerve of mice deficient for the myelin-associated glycoprotein.
    Bartsch U; Montag D; Bartsch S; Schachner M
    Glia; 1995 Jun; 14(2):115-22. PubMed ID: 7558238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A knock-in reporter model of Batten disease.
    Eliason SL; Stein CS; Mao Q; Tecedor L; Ding SL; Gaines DM; Davidson BL
    J Neurosci; 2007 Sep; 27(37):9826-34. PubMed ID: 17855597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
    Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
    J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human intraretinal myelination: axon diameters and axon/myelin thickness ratios.
    FitzGibbon T; Nestorovski Z
    Indian J Ophthalmol; 2013 Oct; 61(10):567-75. PubMed ID: 24212308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease).
    Wager K; Zdebik AA; Fu S; Cooper JD; Harvey RJ; Russell C
    PLoS One; 2016; 11(6):e0157365. PubMed ID: 27327661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.
    Zöller I; Meixner M; Hartmann D; Büssow H; Meyer R; Gieselmann V; Eckhardt M
    J Neurosci; 2008 Sep; 28(39):9741-54. PubMed ID: 18815260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormally increased surface expression of AMPA receptors in the cerebellum, cortex and striatum of Cln3(-/-) mice.
    Kovács AD; Hof C; Pearce DA
    Neurosci Lett; 2015 Oct; 607():29-34. PubMed ID: 26375929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppression alters disease severity in juvenile Batten disease mice.
    Seehafer SS; Ramirez-Montealegre D; Wong AM; Chan CH; Castaneda J; Horak M; Ahmadi SM; Lim MJ; Cooper JD; Pearce DA
    J Neuroimmunol; 2011 Jan; 230(1-2):169-72. PubMed ID: 20937531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease.
    Studniarczyk D; Needham EL; Mitchison HM; Farrant M; Cull-Candy SG
    eNeuro; 2018; 5(2):. PubMed ID: 29780879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis.
    Weimer JM; Benedict JW; Elshatory YM; Short DW; Ramirez-Montealegre D; Ryan DA; Alexander NA; Federoff HJ; Cooper JD; Pearce DA
    Brain Res; 2007 Aug; 1162():98-112. PubMed ID: 17617387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optic nerve degeneration in the DBA/2NNia mouse: is the lamina cribrosa important in the development of glaucomatous optic neuropathy?
    May CA; Mittag T
    Acta Neuropathol; 2006 Feb; 111(2):158-67. PubMed ID: 16453144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.